None EN

Shanghai Longke Pharmaceutical describes new HSD17B13 inhibitors

[] BioWorld 2026-08-11 17:32:11

GastrointestinalShanghai Longke Pharmaceutical describes new HSD17B13 inhibitorsShanghai Longke Pharmaceutical Co. Ltd. has disclosed 17-β-hydroxysteroid dehydrogenase 13 (HSD17B13; 17-β-HSD 13) inhibitors reported to be useful for the treatment of liver diseases.

longke pharmaceutical hsd17b13 inhibitors describes nshanghai

Read Full Article Back to Feed More None